Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roche Wins Genentech After Months-Long Battle

Executive Summary

Score one for tenacity: after nearly eight months of haggling, Roche finally achieved its goal of acquiring Genentech on March 25

You may also be interested in...



Roche Diagnostics Names Diagnostics Leader Schinecker As New CEO

The Swiss company is preparing for a smooth transition in 2023, appointing 20-year Roche veteran and diagnostic chief Thomas Schinecker as its next chief executive as Severin Schwan becomes chairman.

Roche Diagnostics CEO Schinecker Will Succeed Schwan As A New Chapter Unfolds

The Swiss drug maker is preparing for a smooth transition in 2023, appointing 20-year Roche veteran and diagnostic chief Thomas Schinecker as its next chief executive as Severin Schwan becomes chairman.

Sanofi/Genzyme Saga: War Before Peace?

Unless a white knight bidder emerges to thwart Sanofi-Aventis' attempt to acquire Genzyme, and soon, the Cambridge-Mass.-based biotech's best negotiating tactic may be stalling.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS050888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel